$3 billion for global malaria campaign

5 October 2008

A group of international organizations, public and private, has pledged nearly $3.0 billion as part of a new scheme, the Global Malaria Action Plan, which aims to "eradicate malaria" by 2015. The Global Fund to Fight Aids, Tuberculosis and Malaria is raising $1.6 billion and the World Bank a further $1.1 billion. The other major donor is the Bill & Melinda Gates Foundation, which has pledged $168.7 million to fund the Malaria Vaccine Initiative, an R&D project.

Bill Gates, the founder of software giant Microsoft, said: "we need innovation, new drugs and the most dramatic thing we need is vaccine." Some national governments, including the UK, have pledged funds to research the disease.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight